OECD Patients Mortality And Survival Indicators

$79 / year

This dataset contains internationally comparable indicators regarding patients mortality and survival for country members and partners of OECD (The Organization for Economic Co-operation and Development) and for countries in accession negotiations with OECD. The indicators values cover the period 2000-2015.

Complexity

The OECD (The Organization for Economic Co-operation and Development) mission is to promote policies that will improve the economic and social well-being of people around the world. OECD’s work is based on continued monitoring of events in member countries as well as outside OECD area, and includes regular projections of short and medium-term economic developments. The OECD Secretariat collects and analyses data, after which committees discuss policy regarding this information, the Council makes decisions, and then governments implement recommendations. The OECD Health Datasets offers the most comprehensive source of comparable statistics on health and health systems across OECD countries. It is an essential tool to carry out comparative analyses and draw lessons from international comparisons of diverse health systems.

In order to monitor changes in cancer incidence and the quality of care, many countries have developed cancer registries that can analyze and report cancer survival at the national and regional levels. At the international level, a growing number of countries now participate in the global effort to monitor and publish robustly comparable cancer survival estimates via the CONCORD program for the Global Surveillance of Cancer Survival, led by the London School of Hygiene and Tropical Medicine. The OECD collaborates with the CONCORD program to strengthen countries’ capacity in monitoring the effectiveness of their health systems in delivering high-quality cancer care. The OECD’s Health Care Indicators for cancer care currently include the following indicators provided by the CONCORD program:

– Breast cancer 5-year net survival
– Cervical cancer 5-year net survival
– Colorectal cancer 5-year net survival
– Acute lymphoblastic leukaemia

Breast cancer 5-year net survival is measured by dividing the number of women aged 15-99 diagnosed with breast cancer (first primary cancer at the specified site) divided by the expected survival of a comparable group from the general population.

Cervical cancer 5-year net survival is measured by women aged 15-99 diagnosed with cervical cancer (first primary cancer at the specified site) divided by the expected survival of a comparable group from the general population.

Colorectal cancer 5-year net survival is measured by dividing the number of men and women aged 15-99 diagnosed with colorectal cancer (first primary cancer at the specified site) divided by the expected survival of a comparable group from the general population. Data is provided separately for colon and rectal categories of cancers.

Leukaemia is the most common childhood cancer and accounts for over 30% of all cancers diagnosed in children aged below 15 years old in the world (IARC, 2012). Children with acute leukaemia who are free of the disease for 5 years are considered to have been cured as remission after 5 years is rare.

The acute hospital care remains central to the performance of the health care system. Despite substantial gains in the sector, health care providers, researchers and policy makers continue to seek further improvements in the delivery of acute care. As part of these efforts, many countries have developed indicators to measure and monitor acute care performance. Such national efforts have been translated to the international stage through the use of a structured review process whereby expert panels have evaluated and recommended indicators related to cardiac care and acute care. The following three acute care indicators, developed through the HCQI (Health Care Quality Indicators) project, were considered suitable for international comparison:

– The rates of death within 30 days following hospital admissions for acute myocardial infarction (AMI)
– The rates of death within 30 days following hospital admissions for ischemic stroke
– The rates of death within 30 days following hospital admissions for hemorrhagic stroke

For the AMI and stroke indicators, two types of case-fatality indicators are collected. The first reports on the percentage of deaths that occur within 30 days following admission (admission-based), where the death occurred in the same hospital as the initial admission. The second indicator reports on the percentage of deaths that occur within 30 days following admission (patient-based), where the death may have occurred in any hospital or out of hospital. While the second indicator is preferred, not all countries have the capacity to report these data.

The admission-based AMI and stroke indicators are measured by dividing the number of deaths in the same hospital that occurred within 30 days of eligible hospital admission (as defined by the ICD-10 codes and age 45 years and older) by the number of admissions to hospital with primary diagnosis defined by the ICD-10 codes specified and age of 45 years and older, where the admission did not result in a transfer to another acute care hospital, from 1st of January to 31st of December in the specified year.

The patient-based AMI and stroke indicators are measured by dividing the number of deaths in any hospital and out of hospital that occurred within 30 days of eligible hospital admission (as defined by the ICD-10 codes and age 45 years and older) by the number of admissions to hospital with primary diagnosis eligible defined by the ICD-10 codes specified and age of 45 years and older, from 1st of January to 31st December in the specified year.

The HCQI project has identified mental health care as a priority area for further quality of care indicator development, to build on the existing indicators relating to health workforce (e.g. psychiatrists) and health status (e.g. suicide). Through the use of a structured review process, expert panels have previously evaluated and recommended indicators related to quality of mental health care for further consideration. A survey of countries participating in this aspect of the HCQI project subsequently revealed that systems of care vary markedly across countries and the availability of national indicator data suitable for international comparison is limited at this time. The following indicators, developed through the HCQI project, are currently considered suitable for international comparison:

– In-patient suicides among people diagnosed with a mental disorder
– Suicide within 1 year after discharge among patients diagnosed with a mental disorder
– Suicide within 30 days after discharge among patients diagnosed with a mental disorder
– Excess mortality for patients diagnosed with schizophrenia
– Excess mortality for patients diagnosed with severe mental illness
– Excess mortality for patients diagnosed with bipolar disorder

The HCQI project has monitored national information system infrastructures with a view to refine definitions of these indicators and to improve cross-national comparability.

In-patient suicides among people diagnosed with a mental disorder is measured for patients aged 15 and older by dividing the number of patient discharges among denominator cases coded as suicide in the reference year by the number of patients discharged with a principal diagnosis or first two listed secondary diagnosis code of mental health and behavioral disorders in the reference year.

Suicide within 1 year after discharge among patients diagnosed with a mental disorder is measured for patients aged 15 and older by dividing the number of patients among denominator cases that committed suicide within 1 year after discharge by the number of patients discharged alive with a principal diagnosis or first two listed secondary diagnosis code of mental health and behavioral disorders in the reference year. In cases with several admissions during the reference year, the follow up period starts from the last discharge (discharge from a hospital and thus not from one department to another). This indicator required data that links hospital records with deaths after discharge.

Suicide within 30 days after discharge among patients diagnosed with a mental disorder is measured for patients aged 15 and older by dividing the number of patients among denominator cases that committed suicide within 30 days after discharge by the number of patients discharged alive with a principal diagnosis or first two listed secondary diagnosis code of mental health and behavioral disorders in the reference year. In cases with several admissions during the reference year, the follow up period starts from the last discharge (discharge from a hospital and thus not from one department to another).

Excess mortality for patients diagnosed with schizophrenia is measured for patients aged 15-74 years and older as the ratio of two mortality rates:

– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 ever diagnosed with schizophrenia (with the specified ICD-10 codes) as obtained from a register or equivalent data source in the reference year
– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 in the reference year

Excess mortality for patients diagnosed with severe mental illness is measured for patients aged 15-74 years and older as the ratio of two mortality rates:

– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 ever diagnosed with severe mental illness as obtained from a register or equivalent data source in the reference year
– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 in the reference year

Only the countries with a pre-existing registry which records the whole population of severe mental illnesses needed to report this indicator.

Excess mortality for patients diagnosed with bipolar disorder is measured for patients aged 15-74 years and older as the ratio of two mortality rates:

– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 ever diagnosed with bipolar disorder (with the specified ICD-10 codes) as obtained from a register or equivalent data source in the reference year
– Age- and sex-standardized of all deaths and for all persons aged between 15 and 74 in the reference year among all people aged 15-74 in the reference year

Breaks in the time-related continuity of data on which the indicators values are based are specified in the content of dataset. There are also specified the cases were the methodology used for data collection was different (deviations exist).

Date Created

2017-11-10

Last Modified

2017-11-10

Version

2017-11-10

Update Frequency

Irregular

Temporal Coverage

2000-2015

Spatial Coverage

OECD Members and Partners Countries

Source

John Snow Labs => The Organization for Economic Co-operation and Development

Source License URL

John Snow Labs Standard License

Source License Requirements

N/A

Source Citation

N/A

Keywords

OECD Health Care Quality Indicators, OECD Health Care Performance Indicators, Deaths Among Patients, Cancer 5 Year Survival, Mental Disorders And Suicide Rate, Excess Of Mortality, Acute Myocardial Infarction Case Fatalities, Stroke Case Fatalities, In Patient Mortality, In Patient Deaths

Other Titles

OECD Patients Survival And Mortality Related Quality Indicators, Patients Survival And Mortality In OECD Countries

NameDescriptionTypeConstraints
Data_Year_Or_Survival_1st_YearThe year corresponding to the specified indicator value for a country and population group or the first year of the 5 year survival time corresponding to the specified indicator value for a country and population groupdaterequired : 1
Survival_5th_YearThe fifth year of the 5 year survival time corresponding to the specified indicator value for a country and population groupdate-
CountryThe name of the country member or partner of OECD or in accession negotiations with OECDstringrequired : 1
Country_AbbreviationThe abbreviated name of the country member or partner of OECD or in accession negotiations with OECDstringrequired : 1
Country_StatusSpecifies whether the country is member or partner of OECD or has an accession agreement with OECDstringenum : Array required : 1
Indicator_CategorySpecifies a group of indicators related to the patients survival or mortalitystringenum : Array required : 1
IndicatorSpecifies the indicator related to the patients survival or mortalitystringrequired : 1
Measurement_MethodDescribes how the indicator is measuredstringrequired : 1
Disease_ICD_10_CodesSpecifies the disease codes described in the indicator measurement methodologystring-
GenderSpecifies the gender of the demographic group for which the indicator is measuredstringenum : Array required : 1
AgeSpecifies the age of the demographic group for which the indicator is measuredstringenum : Array required : 1
Indicator_ValueThe estimated value of the indicator for the specified population group, year and countrynumberlevel : Ratio
Upper_Value_95_Confidence_LevelThe upper value of the 95% confidence interval of the estimated value of the indicatornumberlevel : Ratio
Lower_Value_95_Confidence_LevelThe lower value of the 95% confidence interval of the estimated value of the indicatornumberlevel : Ratio
Additional_NotesAdditional information related to the indicator value or measurementstring-
Data_Year_Or_Survival_1st_YearSurvival_5th_YearCountryCountry_AbbreviationCountry_StatusIndicator_CategoryIndicatorMeasurement_MethodDisease_ICD_10_CodesGenderAgeIndicator_ValueUpper_Value_95_Confidence_LevelLower_Value_95_Confidence_LevelAdditional_Notes
20102014IsraelISROECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over888987
20102014ItalyITAOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over8686.485.5
20002004TurkeyTUROECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over84.88881.5
20102014FranceFRAOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over86.78885.5
20102014PolandPOLOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over76.57776.1
20002004BelgiumBELOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over84.88683.5
20002004ChileCHLOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over74.681.168.2
20002004ItalyITAOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over84.284.583.8
20002004JapanJPNOECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over85.986.685.2
20002004KoreaKOROECD member5-year survival - CancerBreast cancer five year net survivalAge adjusted percent of survivorsC50.0-50.9Females15 years and over79.280.777.7